Upper GI SSG Meeting Statistics

Background The SSG agreed to start looking at some data/indicators As a starting point, eight metrics were proposed This information is intended as a starting point to help shape our ideas for review of data in the SSG

Questions to consider Are these the right metrics? (We can change but not increase number) Could we discuss different ones each time? How can we get data from the whole region for HPB indicators? Is the data timely enough (most recent available NOGCA data is 15/16) Is it useful to discuss these at SSGs? How could they be more useful?

OG - % patients diagnosed after emergency admission Source: NOGCA audit, patients diagnosed 14/15 financial year % adjusted rate All within NOGCA’s acceptable range Bath 3.1 NBT 6.9 Taunton UH Bristol 5.3 Weston 13.9 Yeovil 5.1

OG - % patients who had a staging CT scan Source: NOGCA audit, patients diagnosed 14/15 financial year All below NOGCA’s acceptable threshold but likely missing data rather than not staged Bath 78 NBT 89 Taunton 88 UH Bristol 81 Weston 90 Yeovil 56

OG - % patients discussed at Specialist MDT with curative treatment pan Source: Bristol cancer register, patients diagnosed 15/16 financial year and eligible for NOGCA audit 41% National % 13-15 (note two year period) per NOGCA audit: 37.6%

OG - % patients who had ≥ 15 lymph nodes removed at resection Source: NOGCA audit, patients diagnosed 14/15 financial year UH Bristol – 90.8% (above national average)

HPB – % pancreatic cancer patients having resection Source: UH Bristol/NBT shared Cancer Register, waiting times dataset Patients first seen at UH Bristol or NBT in 2016/17 financial year: 22%

HPB - % patients with HCC who have a resection or RFA Source: UH Bristol/NBT shared Cancer Register, waiting times dataset Patients first seen at UH Bristol or NBT in 2016/17 financial year: 34%

HPB - Number of resections for liver metastases Source: UH Bristol/NBT shared cancer register, resections undertaken in 2016/17 financial year 44 (plus 5 RFAs)

HPB - % patients with recorded staging Source: UH Bristol/NBT shared cancer register, diagnosed 2016/17 financial year, treated or first seen at UH BristoL 8% (national target 70%) Needs clinical support to state staging in MDT so it can be recorded. National drive to improve staging

Next steps What metrics would we like to review next meeting? (Maximum of 8) How can we ensure complete data? What format would we like the information in?